6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01685268 [Disease Site] Prostate Cancer [Description] 
A Study of HSP90 Inhibitor AT13387 Alone or in Combination with Abiraterone Acetate in the Treatment of Castration-Resistant Prostate Cancer (CRPC) no Longer Responding to Abiraterone
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description